We are live on ! Find out more
YTEN

Yield10 Bioscience, Inc. Common Stock

Delisted

YTEN was delisted on the 15th of May, 2024.

12 hedge funds and large institutions have $6.69M invested in Yield10 Bioscience, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

9% more funds holding

Funds holding: 1112 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

63% less capital invested

Capital invested by funds: $18.2M → $6.69M (-$11.5M)

Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.33%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
1
Increased
1
Reduced
1
Closed
Calls
$35K
Puts
Net Calls
+$35K
Net Calls Change
+$35K

Top Buyers

Rank Fund Capital Flow
1
FA
FCG Advisors
New Jersey
+$77K
2
Group One Trading
Group One Trading
Illinois
+$25.7K

Top Sellers

Rank Fund Capital Flow
1
OIM
Oracle Investment Management
Connecticut
-$513K

YTEN Hedge Fund Activity: Q3 2015 in Review

12 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q3 2015, worth a combined $6.69M — down 63% from $18.2M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new YTEN positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was FCG Advisors, adding an estimated $77K. The largest seller was Oracle Investment Management, cutting an estimated $513K.

  • 12 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q3 2015, up from 11 in Q2 2015.
  • Funds reported $6.69M of Yield10 Bioscience, Inc. Common Stock stock for Q3 2015, down 63% quarter-over-quarter.
  • 1 fund opened new Yield10 Bioscience, Inc. Common Stock positions in Q3 2015 and 0 closed out, a net change of +1 holder.
  • The largest Yield10 Bioscience, Inc. Common Stock buyer in Q3 2015 was FCG Advisors, an estimated $77K added.
  • The largest Yield10 Bioscience, Inc. Common Stock seller in Q3 2015 was Oracle Investment Management, an estimated $513K sold.

Based on aggregated 13F filings for Q3 2015.